Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Omalizumab: clinical use for the management of asthma.

Thomson NC, Chaudhuri R.

Clin Med Insights Circ Respir Pulm Med. 2012;6:27-40. doi: 10.4137/CCRPM.S7793. Epub 2012 Jun 12.

PMID:
22745565
[PubMed]
Free PMC Article
2.

Omalizumab: a review of its use in the management of allergic asthma.

Bang LM, Plosker GL.

Treat Respir Med. 2004;3(3):183-99. Review.

PMID:
15219177
[PubMed - indexed for MEDLINE]
3.

Spotlight on omalizumab in allergic asthma.

Bang LM, Plosker GL.

BioDrugs. 2004;18(6):415-8. Review.

PMID:
15571425
[PubMed - indexed for MEDLINE]
4.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
[PubMed - indexed for MEDLINE]
5.

A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.

Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. Review.

PMID:
19075985
[PubMed - indexed for MEDLINE]
6.

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma.

D'Amato G, Salzillo A, Piccolo A, D'Amato M, Liccardi G.

Ther Clin Risk Manag. 2007 Aug;3(4):613-9.

PMID:
18472983
[PubMed]
Free PMC Article
7.

Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.

Chipps BE, Figliomeni M, Spector S.

Allergy Asthma Proc. 2012 Sep-Oct;33(5):377-85. doi: 10.2500/aap.2012.33.3599.

PMID:
23026179
[PubMed - indexed for MEDLINE]
8.

Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.

Ruffin CG, Busch BE.

Am J Health Syst Pharm. 2004 Jul 15;61(14):1449-59. Review.

PMID:
15332692
[PubMed - indexed for MEDLINE]
9.

Omalizumab in the management of patients with allergic (IgE-mediated) asthma.

Sandström T.

J Asthma Allergy. 2009 May 8;2:49-62.

PMID:
21437144
[PubMed]
Free PMC Article
10.

Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).

D'Amato G, Bucchioni E, Oldani V, Canonica W.

Treat Respir Med. 2006;5(6):393-8.

PMID:
17154668
[PubMed - in process]
11.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.

Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N.

Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Review.

PMID:
22950547
[PubMed - indexed for MEDLINE]
12.

Anti-IgE antibodies for the treatment of asthma.

Buhl R.

Curr Opin Pulm Med. 2005 Jan;11(1):27-34. Review.

PMID:
15591885
[PubMed - indexed for MEDLINE]
13.

Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma.

Kulus M, Hébert J, Garcia E, Fowler Taylor A, Fernandez Vidaurre C, Blogg M.

Curr Med Res Opin. 2010 Jun;26(6):1285-93. doi: 10.1185/03007991003771338.

PMID:
20377320
[PubMed - indexed for MEDLINE]
14.

Omalizumab: the evidence for its place in the treatment of allergic asthma.

McNicholl DM, Heaney LG.

Core Evid. 2008 Jun;3(1):55-66. doi: 10.3355/ce.2008.012.

PMID:
20694084
[PubMed]
Free PMC Article
15.

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.

Lanier B, Bridges T, Kulus M, Taylor AF, Berhane I, Vidaurre CF.

J Allergy Clin Immunol. 2009 Dec;124(6):1210-6. doi: 10.1016/j.jaci.2009.09.021. Epub .

PMID:
19910033
[PubMed - indexed for MEDLINE]
16.

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Holgate ST, Djukanović R, Casale T, Bousquet J.

Clin Exp Allergy. 2005 Apr;35(4):408-16. Review.

PMID:
15836747
[PubMed - indexed for MEDLINE]
17.

The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden.

Dewilde S, Turk F, Tambour M, Sandström T.

Curr Med Res Opin. 2006 Sep;22(9):1765-76.

PMID:
16968580
[PubMed - indexed for MEDLINE]
18.

Evaluation of omalizumab from a health plan perspective.

Belliveau PP, Lahoz MR.

J Manag Care Pharm. 2005 Nov-Dec;11(9):735-45. Review.

PMID:
16300417
[PubMed - indexed for MEDLINE]
Free Article
19.

Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.

Nowak D.

Respir Med. 2006 Nov;100(11):1907-17. Epub 2006 Sep 1. Review.

PMID:
16949266
[PubMed - indexed for MEDLINE]
Free Article
20.

Omalizumab: a novel therapy for allergic asthma.

Davis LA.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1236-42. Epub 2004 Jun 8. Review.

PMID:
15187202
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk